Where Guardant Health Stands With Analysts
Portfolio Pulse from Benzinga Insights
In the last three months, 7 analysts have published ratings on Guardant Health (NASDAQ:GH), with 6 being bullish and 1 somewhat bullish. The average 12-month price target is $33.71, down from $37.75. Analysts have adjusted their ratings and price targets based on recent developments.
June 28, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Guardant Health has received 7 analyst ratings in the last three months, with 6 bullish and 1 somewhat bullish. The average 12-month price target is $33.71, down from $37.75. Analysts have adjusted their ratings and price targets based on recent developments.
The majority of analysts are bullish on Guardant Health, which is a positive indicator for the stock. However, the average price target has decreased, reflecting some caution. The overall sentiment is likely to have a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100